Cloned, CD117 selected human amniotic fluid stem cells are capable of modulating the immune response

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Moorefield, Emily C ^a   McKee, Elizabeth E ^a   Solchaga, Luis ^b   Orlando, Guisseppe ^a,c   Yoo, James J ^a   Walker, Steve ^a   Furth, Mark E ^a   Bishop, Colin E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; STEM CELL FACTOR RECEPTOR; CYTOKINE;

AMNION FLUID; ARTICLE; CELL ACTIVATION; CELL CLONE; CELL COMMUNICATION; CELL RENEWAL; CONTROLLED STUDY; CYTOKINE RELEASE; GROWTH RELATED ONCOGENE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; INFLAMMATION; LYMPHOCYTE ACTIVATION; MESENCHYMAL STEM CELL; MONOCYTE; ONCOGENE; PROTEIN FAMILY; STEM CELL; CULTURE MEDIUM; CYTOLOGY; HEALTH CARE FACILITY; IMMUNITY; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM;

AMNIOTIC FLUID; CLONE CELLS; CULTURE MEDIA, CONDITIONED; CYTOKINES; HUMANS; IMMUNITY; IMMUNOTHERAPY; INFLAMMATION; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELLS; TISSUE BANKS;

EID: 80055049727     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026535     Document Type: Article

References (39)

1. Ma T, (2010) Mesenchymal stem cells: From bench to bedside. World J Stem Cells 2: 13-17.
2. Puissant B, Barreau C, Bourin P, Clavel C, Corre J, et al. (2005) Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129: 118-129.
3. Gimble JM, Katz AJ, Bunnell BA, (2007) Adipose-derived stem cells for regenerative medicine. Circ Res 100: 1249-1260.
4. Phinney DG, Prockop DJ, (2007) Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 25: 2896-2902.
5. Schaffler A, Buchler C, (2007) Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells 25: 818-827.
6. Bruder SP, Jaiswal N, Haynesworth SE, (1997) Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64: 278-294.
7. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI, (1992) Characterization of cells with osteogenic potential from human marrow. Bone 13: 81-88.
8. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
9. Le Blanc K, (2003) Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5: 485-489.
10. Nauta AJ, Fibbe WE, (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506.
11. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O, (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57: 11-20.
12. Maitra B, Szekely E, Gjini K, Laughlin MJ, Dennis J, et al. (2004) Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 33: 597-604.
13. Augello A, Tasso R, Negrini SM, Amateis A, Indiveri F, et al. (2005) Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol 35: 1482-1490.
14. Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, et al. (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105: 2214-2219.
15. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, et al. (2003) Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101: 3722-3729.
16. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC, (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75: 389-397.
17. Groh ME, Maitra B, Szekely E, Koc ON, (2005) Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol 33: 928-934.
18. Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, et al. (2006) Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24: 386-398.
19. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, et al. (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2: 141-150.
20. Chen SL, Fang WW, Qian J, Ye F, Liu YH, et al. (2004) Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Chin Med J (Engl) 117: 1443-1448.
21. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, et al. (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 99: 8932-8937.
22. Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, et al. (2002) Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30: 215-222.
23. Le Blanc K, Samuelsson H, Gustafsson B, Remberger M, Sundberg B, et al. (2007) Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 21: 1733-1738.
24. Mushtaq M, Oskouei BN, Hare JM, (2011) Cell therapy for heart disease: to genetically modify or not, that is the question. Circ Res 108: 398-401.
25. Sensebe L, Bourin P, (2009) Mesenchymal stem cells for therapeutic purposes. Transplantation 87: S49-53.
26. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, et al. (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25: 100-106.
27. Gosden CM, (1983) Amniotic fluid cell types and culture. Br Med Bull 39: 348-354.
28. Fauza D, (2004) Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol 18: 877-891.
29. Kolambkar YM, Peister A, Soker S, Atala A, Guldberg RE, (2007) Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol 38: 405-413.
30. Ryan JM, Barry FP, Murphy JM, Mahon BP, (2005) Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2: 8.
31. Betz AG, (2010) Immunology. Have you seen your mother, baby. Science 330: 1635-1636.
32. Sessarego N, Parodi A, Podesta M, Benvenuto F, Mogni M, et al. (2008) Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica 93: 339-346.
33. Lennon DP, Caplan AI, (2006) Isolation of human marrow-derived mesenchymal stem cells. Exp Hematol 34: 1604-1605.
34. Klassen HJ, Imfeld KL, Kirov II, Tai L, Gage FH, et al. (2003) Expression of cytokines by multipotent neural progenitor cells. Cytokine 22: 101-106.
35. Liu LH, Sun Z, Sun QY, Huang YJ, Man QH, et al. (2005) Study on biological characteristics of cultured rhesus mesenchymal stem cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 13: 417-421.
36. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL, (1998) Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176: 57-66.
37. Mracek T, Cannon B, Houstek J, (2004) IL-1 and LPS but not IL-6 inhibit differentiation and downregulate PPAR gamma in brown adipocytes. Cytokine 26: 9-15.
38. Krishnaswamy G, Kelley J, Yerra L, Smith JK, Chi DS, (1999) Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res 19: 91-104.
39. Perin L, Sedrakyan S, Giuliani S, Da Sacco S, Carraro G, et al. (2010) Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One 5: e9357.